CD274 and cancer: Therefore, PD-L1 inhibitors exert a greater effect than PD-1 inhibitors by blocking PD-L1 on DCs, which in turn relieves the inhibition of B7.1 and further restores DC function to facilitate the initiation of anti-cancer T cell immunity.